在COPD中,CH25H/25-HC通过AMPK/STAT6通路依赖的M2巨细胞极化促进肺纤维化

Ying Li1, Guangzhi Xiao1, Xianghui Fu1

  • 1Department of Clinical Immunology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.

Immunobiology
|May 1, 2025
PubMed
概括

CH25H/25-胆固醇 (25-HC) 在慢性阻塞性肺病 (COPD) 中通过激活AMPK/STAT6依赖的M2巨细胞两极分化来促进肺纤维化. 向CH25H为COPD相关纤维化提供了一个潜在的治疗策略.

相关概念视频

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.7K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
170